With a R&D team composed of world-class scientists, BeautyPalUS holds numerous global patents and publications:
Roger Xie, Founder, President and CEO of Conform Pharmaceuticals Inc., a cancer platform technology company, developing drugs against single common mechanism that hits numerous cancer pathways, even in cancer stem cells. Prior to Conform, Dr. Xie was co-founder and EVP, Head of Global Development and Chair of Scientific Advisory Board at China PharmaHub Corp (Stock Symbol: CPHB).
Eric Wang, BD Director, former senior equity Analyst with Pingan of China. Prior to Pingan, Eric was a senior associate with Novartis in US. Extensive experience in design and synthesis of small molecules, nature product analogs as antiviral / anticancer agents.
Mingna Song, R&D Director, Prior to BeautyPalUS, Mingna was a senior research scientist with KV Pharmaceutical Company(US). Expertise in research and product development of multiple liquid and semi-solid dosage forms, process optimization and new drug delivery technologies, i.e., design of modified release drug delivery systems (DDS), and drug solubility/stability/bioavailability enhancement.
